Clinical trial
PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants…
NCT00472043 · Galderma R&D, Industry · Completed
Key facts
| NCT number | NCT00472043 |
|---|---|
| Title | PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma |
| Official title | A Multicentre, Phase III, Double Blind Study of Photodynamic Therapy (PDT) With Metvix® 160 mg/g Cream in Comparison to PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma |
| Lead sponsor | Galderma R&D, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Basal Cell Carcinoma |
| Intervention type | Drug |
| Interventions | PDT with Metvix 160 mg/g cream, Placebo |
| Enrollment | 66 |
| Start date | Oct 1, 2000 |
| Primary completion | Sep 30, 2002 |
| Completion | Sep 30, 2002 |
| First posted | May 11, 2007 |
| Last update posted | Aug 6, 2024 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: